Pear Therapeutics To Become Public Company Through Merger With Thimble Point

Pear Therapeutics will become a public company through a merger with Thimble Point Acquisition Corp. (THMA).

The merger values the combined company at a pro forma equity value of about $1.6 billion. Pursuant to the Business Combination, the Combined Company is expected to have about $450 million of net cash on its balance sheet upon the closing of the transaction.

Upon closing of the business combination, the combined company will be named Pear Holdings Corp. and will be led by Pear's current management team. The combined company's common stock is expected to be listed on Nasdaq under the new ticker symbol "PEAR."

The merger is expected to be completed in the second half of 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sturtevant, Wisconsin-based BRP U.S. Inc. is recalling around 20 models of Side-by-Side vehicles citing fire risk, the U.S. Consumer Product Safety Commission. The recall involves about 34,400 units of Model Years 2020 and 2021 Can-AM Defender HD10 side-by-side vehicles. While reporting financial results for the second quarter on Friday, technology company Honeywell international Inc. (HON) raised its adjusted earnings and sales guidance for the full-year 2021, based on the second-quarter performance and management's outlook for the remainder of the year. For fiscal... Shares of Vodafone Group Plc were gaining around 2 percent in the morning trading in London after the British telecom major reported higher revenues in its first quarter. Looking ahead, the company said it is on track to deliver fiscal year 2022 guidance, with Adjusted EBITDAaL expected to be between 15.0 billion euros - 15.4 billion euros and Adjusted free cash flow of at least 5.2 billion euros
Follow RTT